These results, the fact that they're negative, does not invalidate that inflammation plays a very important role in ...

A Novartis drug lowered a risk marker for cardiovascular disease but did not lower chance of heart attack or stroke.

The model is a test of Trump's most-favored nation approach to drug pricing, though its impact is likely to be limited.

Small changes are important, Cohen said about the trial, whose mission was to measure blood pressure reduction, not ...

Pithy intro text about the biopharma milieu. Novartis cites more tumor reports after Zolgensma Novartis has disclosed seven ...

Calley Means, a MAHA leader who just resigned from the Trump administration, says Americans "are being duped and gaslighted ...

Few Americans are familiar with kratom, despite public health messaging and rising use. So what is it, and who's using it?

A new paper, published yesterday in Science, offers compelling evidence of ritual cannabis use in a 2,800-year-old Siberian ...

John writes about the politics of health care, and he is the author of the twice-weekly D.C. Diagnosis newsletter. You can reach John on Signal at John_Wilkerson.07. WASHINGTON — Democrats decisively ...

The Trump administration is facing another lawsuit over its sweeping changes to Medicaid less than a week after a federal ...

For AI to achieve its full potential in women’s health, medical records need to tell the complete story,” experts write.

Voters in 2026 midterm elections decided state health policy ballot measures on abortion rights, marijuana laws, science ...